(Q37150315)

18 August 2017

1 reference

title

Monitoring the impact of vaccines postlicensure: new challenges, new opportunities (English)

1 reference

18 August 2017

1

Anne Schuchat

1 reference

18 August 2017

Beth P Bell

2

1 reference

18 August 2017

1 May 2008

1 reference

Expert Review of Vaccines

18 August 2017

1 reference

18 August 2017

7

1 reference

18 August 2017

4

1 reference

18 August 2017

437-456

1 reference

Historical comparisons of morbidity and mortality for vaccine-preventable diseases in the United States

18 August 2017

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.437

Use of vaccine surveillance data in the evaluation of safety of vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.437

Fatal respiratory disease due to Corynebacterium diphtheriae: case report and review of guidelines for management, investigation, and control

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.437

The burden of varicella complications before the introduction of routine varicella vaccination in Germany.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.437

Active bacterial core surveillance of the emerging infections program network

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.437

Decline in Invasive Pneumococcal Disease after the Introduction of Protein–Polysaccharide Conjugate Vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.437

The changing epidemiology of hepatitis B in the United States. Need for alternative vaccination strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.437

From the center for disease control. Epidemiology of pneumococcal serotypes in the United States, 1978--1979.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.437

Rotavirus in Asia: the value of surveillance for informing decisions about the introduction of new vaccines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.437

The Alaska Haemophilus influenzae type b experience: lessons in controlling a vaccine-preventable disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.437

Haemophilus influenzae Type b disease among Amish children in Pennsylvania: reasons for persistent disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.437

Implications of a 2005 measles outbreak in Indiana for sustained elimination of measles in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.437

Patterns of transmission in measles outbreaks in the United States, 1985-1986.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.437

The role of measles elimination in development of a national immunization program

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.437

Loss of vaccine-induced immunity to varicella over time

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.437

Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.437

Decline of Childhood Haemophilus influenzae Type b (Hib) Disease in the Hib Vaccine Era

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.437

Quantifying the impact of hepatitis A immunization in the United States, 1995-2001.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.437

Ukraine, 1992: first assessment of diphtheria vaccine effectiveness during the recent resurgence of diphtheria in the Former Soviet Union

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.437

Diphtheria toxoid vaccine effectiveness: A case-control study in Russia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.437

Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.437

The contribution of the case-control approach to vaccine evaluation: Pneumococcal and Haemophilus influenzae type B PRP vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.437

Age-specific differences in duration of clinical protection after vaccination with meningococcal polysaccharide A vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.437

Varicella disease after introduction of varicella vaccine in the United States, 1995-2000

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.437

Incidence of hepatitis A in the United States in the era of vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.437

Vaccine supply problems: a perspective of the Centers for Disease Control and Prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.437

Elimination of Haemophilus influenzae type b (Hib) disease from The Gambia after the introduction of routine immunisation with a Hib conjugate vaccine: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.437

Impact of childhood vaccination on racial disparities in invasive Streptococcus pneumoniae infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.437

Epidemiology of hepatitis B and hepatitis B virus infection in United States children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.437

Individual and community risks of measles and pertussis associated with personal exemptions to immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.437

Nonmedical Exemptions to School Immunization Requirements

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.437

The rise and fall of epidemic Neisseria meningitidis serogroup W135 meningitis in Burkina Faso, 2002-2005.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.437

Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.437

Vaccine escape recombinants emerge after pneumococcal vaccination in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.437

VACCINE-DERIVED POLIOVIRUSES AND THE ENDGAME STRATEGY FOR GLOBAL POLIO ERADICATION *

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.437

Hepatitis a molecular epidemiology in the United States, 1996-1997: sources of infection and implications of vaccination policy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.437

Adamantane resistance among influenza A viruses isolated early during the 2005-2006 influenza season in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.437

Antimicrobial resistance of Neisseria meningitidis in the United States, 1997. The Active Bacterial Core Surveillance (ABCs) Team.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.437

Estimating the undetected burden of influenza hospitalizations in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.437

Epidemiology of respiratory infections in young children: insights from the new vaccine surveillance network

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.437

Active surveillance of vaccine safety: a system to detect early signs of adverse events

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.437

Effectiveness of influenza vaccine in the community-dwelling elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.437

The challenge and potential of childhood immunization registries

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.437

Intussusception among infants given an oral rotavirus vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.437

Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.437

Influenza vaccine effectiveness among 50-64-year-old persons during a season of poor antigenic match between vaccine and circulating influenza virus strains: Colorado, United States, 2003-2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.437

Evidence of bias in estimates of influenza vaccine effectiveness in seniors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.437

A new global framework for immunization monitoring and surveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.437

Influenza-Associated Deaths among Children in the United States, 2003–2004

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.437

Protective efficacy of a monovalent oral type 1 poliovirus vaccine: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.437

Multistate Surveillance for Laboratory-Confirmed, Influenza-Associated Hospitalizations in Children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.437

Safety and Efficacy of an Attenuated Vaccine against Severe Rotavirus Gastroenteritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.437

Will pediatricians adopt the new rotavirus vaccine?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.437

Effect of Pneumococcal Conjugate Vaccine on Nasopharyngeal Colonization among Immunized and Unimmunized Children in a Community‐Randomized Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.437

21 January 2018

Identifiers

DOI

10.1586/14760584.7.4.437

1 reference

18 August 2017

1 reference

PubMed ID

18444891